[ad_1] With discussions to sell stake in JB Chemicals and Pharmaceuticals running into a wall over valuation and pricing, private equity firm KKR is understood to be weighing the prospect of exiting through market sales, via the block deal windows of Indian exchanges, sources said. The $2 billion deal has been in the making for […]